HealthcareServices

Common Warts Market Research: Growth Projections and Trends 2030

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the common warts market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Common Warts Market expected to reach by 2030?

The common warts market has shown robust expansion over recent years. Its valuation is predicted to climb from $2.25 billion in 2025 to $2.38 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.8%. This historical growth can be linked to factors like the increasing occurrence of HPV infections, the widespread adoption of cryotherapy treatments, the availability of topical salicylic acid products, the expansion of dermatology clinics, and a heightened awareness of skin health.

The common warts market size is projected to experience significant growth in the coming years. By 2030, its valuation is set to reach $2.96 billion, expanding at a compound annual growth rate (CAGR) of 5.6%. This projected growth during the forecast period is fueled by several factors, including an escalating demand for non-invasive dermatological solutions, a heightened emphasis on cosmetic dermatology, the proliferation of homecare dermatology products, the increasing embrace of laser-based therapies, and enhanced investment in immunomodulatory treatments. Furthermore, major trends anticipated in this period involve continuous advancements in minimally invasive wart removal techniques, a growing adoption of combination therapy approaches, greater availability of over-the-counter treatments, the expanding utilization of immunotherapy-based topicals, and a wider array of home-based treatment options.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

What Drivers Are Driving Adoption Within The Common Warts Market?

The rising occurrence of viral infections is anticipated to boost the common warts market’s expansion in the future. Viral infections are conditions that occur when viruses invade, replicate, and disseminate throughout the body, impacting cells and the immune system. This surge in viral infection cases is fueled by factors such as global interconnectedness, climatic shifts, increased urban living, forest depletion, and compromised immune systems. Treatment for common warts focuses on the human papillomavirus (HPV), which causes wart development, offering crucial assistance to individuals with viral infections by limiting viral transmission, easing pain, and encouraging recovery. This process thereby averts issues like subsequent infections or marks and enhances the patient’s well-being. For example, data from 2024 by the Centers for Disease Control and Prevention, a US-based government agency, indicated that in 2022, PCR-confirmed varicella cases saw a 62% increase, moving from 29% to 47% in the preceding five years. Additionally, in January 2023, the National Foundation for Infectious Diseases, a US-based health organization, reported approximately 14 million new cases of HPV infection each year in the United States. Consequently, the heightened frequency of viral infections is propelling the expansion of the common warts market.

What Segments Are Included Within The Common Warts Market?

The common warts market covered in this report is segmented –

1) By Treatment Method: Cryotherapy, Laser Treatment, Electrosurgery, Topical Medications

2) By Patient Demographics: Children, Adults, Elderly

3) By Disease Stage: Initial Stage, Moderate Stage, Severe Stage

4) By End User: Hospitals, Dermatology Clinics, Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy, Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy, Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal, High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy, Immunotherapy-Based Topicals, Retinoid-Based Therapy

What Trends Are Projected To Support The Growth Of The Common Warts Market?

Leading enterprises within the common warts market are prioritizing the advancement of novel therapeutic approaches, specifically dermatological treatments, in response to the escalating demand for efficacious and readily available remedies, with the objective of enhancing patient results and augmenting their footprint in the dermatology domain. These therapies encompass treatments for various skin ailments, such as infections, inflammatory conditions, and other disorders. For instance, in May 2024, Verrica Pharmaceuticals, a US-based pharmaceutical company, forged a licensing agreement with Torii Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company. This partnership is designed to financially support a worldwide Phase 3 clinical trial for YCANTH, a treatment for common warts. The accord facilitates the advanced development of YCANTH, thereby broadening its potential international presence. Torii Pharmaceuticals is set to provide capital to propel the research forward. This joint effort fortifies the dermatology portfolios and global market standing of both entities.

Who Are The Core Companies Influencing Trends In The Common Warts Market?

Major companies operating in the common warts market are GSK plc, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Novan Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., Scholl’s Wellness Company, Naturasil, Bausch Health Companies Inc., Viatris Inc., Sanofi S.A., Pfizer Inc., Bayer AG, Novartis AG, Dr Reddy’s Laboratories Ltd, Cipla Inc, Taro Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, AIM ImmunoTech Inc, Phio Pharmaceuticals Corp, Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Lumenis Be Ltd, Almirall S.A, Daiichi Sankyo Company Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Common Warts Market?

North America was the largest region in the common warts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Common Warts Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21154&type=smp

Browse Through More Reports Similar to the Global Common Warts Market 2026, By The Business Research Company

Specialty Malt Market Report 2026

https://www.thebusinessresearchcompany.com/report/specialty-malt-global-market-report

Warts Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

Asphalt Shingles Market Report 2026

https://www.thebusinessresearchcompany.com/report/asphalt-shingles-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795